RecombinantRajicellexpressinganengineeredTcellreceptor(TCR)activator.

ThawMedium2(BPSCat.#60184):RPMI1640medium(LifeTechnologies,#A10491-01)supplementedwith10%FBS(LifeTechnologies,#26140-079),1%Penicillin/Streptomycin(Hyclone,#SV30010.01).

CompleteGrowthMedium:ThawMedium2(BPSBioscience,,#60184)+200μg/mlofHygromycinB(Hyclone,#SV30070.01).Cellsshouldbegrownat37°Cwith5%CO2usingcompletegrowthmedium(ThawMedium2+200μg/mlofHygromycinB).

Contactusforpricing.

LicenseDisclosure:Purchaseofthiscelllinegrantsyouwitha10-yearlicensetousethiscelllineinyourimmediatelaboratory,forresearchuseonly.Thislicensedoesnotpermityoutoshare,distribute,sell,sublicense,orotherwisemakethecelllineavailableforusetootherlaboratories,departments,researchinstitutions,hospitals,universities,orbiotechcompanies.Thelicensedoesnotpermituseofthiscelllineinhumansorfortherapeuticordruguse.Thelicensedoesnotpermitmodificationofthecelllineinanyway.InappropriateuseordistributionofthiscelllinewillresultinrevocationofthelicenseandresultinanimmediateceaseofsalesanddistributionofBPSproductstoyourlaboratory.BPSdoesnotwarrantthesuitabilityofthecelllineforanyparticularuse,anddoesnotacceptanyliabilityinconnectionwiththehandlingoruseofthecellline.Modificationsofthiscellline,transfertoanotherfacility,orcommercialuseofthecellsmayrequireaseparatelicenseandadditionalfees;contactsales@bpSBIoscience.comfordetails.PublicationsusingthiscelllineshouldreferenceBPSBioscience,Inc.,SanDiego.